Trinh Phung - Apr 12, 2022 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Signature
/s/ Wade Estey, as attorney-in-fact for Trinh Phung
Stock symbol
SWAV
Transactions as of
Apr 12, 2022
Transactions value $
-$684,763
Form type
4
Date filed
4/14/2022, 05:36 PM
Previous filing
Feb 24, 2022
Next filing
Apr 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale -$148K -700 -2.13% $210.73 32.2K Apr 12, 2022 Direct F1, F2, F3
transaction SWAV Common Stock Sale -$33.4K -158 -0.49% $211.22 32K Apr 12, 2022 Direct F1, F4
transaction SWAV Common Stock Sale -$73.9K -348 -1.09% $212.26 31.7K Apr 12, 2022 Direct F1, F5
transaction SWAV Common Stock Sale -$42.9K -200 -0.63% $214.25 31.5K Apr 12, 2022 Direct F1, F6
transaction SWAV Common Stock Sale -$108K -500 -1.59% $216.10 31K Apr 12, 2022 Direct F1, F7
transaction SWAV Common Stock Sale -$21.7K -100 -0.32% $217.00 30.9K Apr 12, 2022 Direct F1, F8
transaction SWAV Common Stock Sale -$103K -470 -1.52% $219.08 30.4K Apr 12, 2022 Direct F1, F9
transaction SWAV Common Stock Sale -$110K -500 -1.65% $220.18 29.9K Apr 12, 2022 Direct F1, F10
transaction SWAV Common Stock Sale -$22.1K -100 -0.33% $221.14 29.8K Apr 12, 2022 Direct F1, F11
transaction SWAV Common Stock Sale -$22.2K -100 -0.34% $222.41 29.7K Apr 12, 2022 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/10/2022.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.06 to $210.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The reported total includes an aggregate 75 shares the Reporting Person has acquired since her Form 4 report filed on February 24, 2022 in exempt transactions through automatic payroll deduction and purchase features of the Issuers Employee Stock Purchase Plan, which is a qualified tax-conditioned plan pursuant to Section 423 of the Internal Revenue Code.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $211.06 to $211.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.16 to $212.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $213.79 to $214.71. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $215.54 to $216.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F8 All reported securities were sold at a price of $217.00.
F9 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $218.57 to $219.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F10 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.62 to $220.56. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F11 All reported securities were sold at a price of $221.14.
F12 All reported securities were sold at a price of $222.41.